Marker Therapeutics, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
New Enterprise Associates and its affiliates reported a decrease in their beneficial ownership of Marker Therapeutics, Inc. common stock to 9.9% due to an increase in the total outstanding shares.
NASDAQ
SCHEDULE: Insider Sells Marker Therapeutics Shares
John R. Wilson's trust has reduced its beneficial ownership in Marker Therapeutics, Inc. to below 5% through a series of open market sales.
NASDAQ
SCHEDULE: Insider Sells Marker Therapeutics Shares
John R. Wilson's trust has reduced its beneficial ownership in Marker Therapeutics, Inc. to 5.10% through recent stock sales.
NASDAQ
New Enterprise Associates' beneficial ownership in Marker Therapeutics, Inc. has decreased to 12.6% due to an increase in the company's outstanding common stock.